When people's kidneys fail (end-stage kidney disease), they need either a transplant or dialysis to keep performing the kidney's functions. Dialysis can involve either regular visits to hospital for time on an artificial kidney machine (haemodialysis), or home dialysis. Home dialysis (CAPD - continuous ambulatory peritoneal dialysis) is a 'do it yourself' option that does not require a machine. It involves a tube permanently inserted through the abdomen to allow a fluid called dialysate to be emptied and replaced every day. The review found only one trial comparing the effects of CAPD and haemodialysis. No conclusions could be drawn.
閱讀完整摘要
Renal replacement therapy (RRT) with dialysis and transplantation is the only means of sustaining life for patients with end-stage kidney disease (ESKD). Although transplantation is the treatment of choice, the number of donor kidneys are limited and transplants may fail. Hence many patients require long-term or even life-long dialysis. Continuous ambulatory peritoneal dialysis (CAPD) is an alternative to hospital or home haemodialysis for patients with ESKD.
目的
To assess the benefits and harms of CAPD versus hospital or home haemodialysis for adults with ESKD.
搜尋策略
We searched the Cochrane Central Register of Controlled Trials (CENTRAL in The Cochrane Library Issue 12, 2011), the Cochrane Renal Group's specialised register (12 January 2012), MEDLINE (1966 to May 2002), EMBASE (1980 to May 2002), BIOSIS, CINAHL, SIGLE and NRR without language restriction. Reference lists of retrieved articles and conference proceedings were searched and known investigators and biomedical companies were contacted.
Date of last search: 12 January 2012.
選擇標準
Randomised controlled trials (RCTs) or quasi-RCTs comparing CAPD to hospital or home haemodialysis for adults with ESKD were to be included.
資料收集與分析
Two authors independently assess the methodological quality of studies. Data was abstracted from included studies onto a standard form by one author and checked by another. Statistical analyses were performed using the random-effects model and the results expressed as risk ratio (RR) for dichotomous outcomes and mean difference (MD) for continuous outcomes with 95% confidence intervals (CI).
主要結果
One trial, reported in abstract form only, was located in the most recent search. There was no statistical difference in death or quality adjusted life years score at two years between peritoneal dialysis or haemodialysis patients.
作者結論
There is Insufficient data to allow conclusions to be drawn about the relative effectiveness of CAPD compared with hospital or home haemodialysis for adults with ESKD. Efforts should be made to start and complete adequately powered RCTs, which compare the different dialysis modalities.
